Publications by authors named "Luisa Mosti"

Claim this Profile
C
CoMFA and CoMSIA analyses on 1,2,3,4-tetrahydropyrrolo[3,4-b]indole and benzimidazole derivatives as selective CB2 receptor agonists.
Elena Cichero, Sara Cesarini, Luisa Mosti, Paola Fossa

J Mol Model· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CoMFA and CoMSIA analyses on 4-oxo-1,4-dihydroquinoline and 4-oxo-1,4-dihydro-1,5-, -1,6- and -1,8-naphthyridine derivatives as selective CB2 receptor agonists.
Elena Cichero, Sara Cesarini, Luisa Mosti, Paola Fossa

J Mol Model· April 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acylthiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors: docking studies and ligand-based CoMFA and CoMSIA analyses.
Elena Cichero, Sara Cesarini, Andrea Spallarossa, Luisa Mosti, Paola Fossa

J Mol Model· July 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The XIXth National Meeting on Medicinal Chemistry: Verona, Italy.
Livio Brasili, Daniele Donati, Luisa Mosti

ChemMedChem· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Thiocarbamates as non-nucleoside HIV-1 reverse transcriptase inhibitors: docking-based CoMFA and CoMSIA analyses.
Elena Cichero, Sara Cesarini, Paola Fossa, Andrea Spallarossa, Luisa Mosti

Eur J Med Chem· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Computational studies of the binding mode and 3D-QSAR analyses of symmetric formimidoester disulfides: a new class of non-nucleoside HIV-1 reverse transcriptase inhibitor.
Elena Cichero, Sara Cesarini, Andrea Spallarossa, Luisa Mosti, Paola Fossa

J Mol Model· April 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, biological evaluation and docking studies of 4-amino substituted 1H-pyrazolo[3,4-d]pyrimidines.
Silvia Schenone, Chiara Brullo, Olga Bruno, Francesco Bondavalli, Luisa Mosti

Eur J Med Chem· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rational design, synthesis and biological evaluation of new 1,5-diarylpyrazole derivatives as CB1 receptor antagonists, structurally related to rimonabant.
Giulia Menozzi, Paola Fossa, Elena Cichero, Andrea Spallarossa, Angelo Ranise, Luisa Mosti

Eur J Med Chem· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploring the binding features of rimonabant analogues and acyclic CB1 antagonists: docking studies and QSAR analysis.
Elena Cichero, Giulia Menozzi, Andrea Spallarossa, Luisa Mosti, Paola Fossa

J Mol Model· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Substituted pyrazolo[3,4-b]pyridines as potent A1 adenosine antagonists: synthesis, biological evaluation, and development of an A1 bovine receptor model.
Tiziano Tuccinardi, Silvia Schenone, Francesco Bondavalli, Chiara Brullo, Olga Bruno, Luisa Mosti

ChemMedChem· June 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and in vitro antiplatelet activity of new 4-(1-piperazinyl)coumarin derivatives. Human platelet phosphodiesterase 3 inhibitory properties of the two most effective compounds described and molecular modeling study on their interactions with phosphodiesterase 3A catalytic site.
Giorgio Roma, Mario Di Braccio, Giancarlo Grossi, Daniela Piras, Giuliana Leoncini, Luisa Mosti

J Med Chem· June 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Affinity prediction on A1 adenosine receptor agonists: the chemometric approach.
Paola Fossa, Luisa Mosti, Francesco Bondavalli, Silvia Schenone, Angelo Ranise

Bioorg Med Chem· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyrazolo[3,4-d]pyrimidines as potent antiproliferative and proapoptotic agents toward A431 and 8701-BC cells in culture via inhibition of c-Src phosphorylation.
Fabio Carraro, Antonella Naldini, Annalisa Pucci, Giada A Locatelli, Giovanni Maga, Luisa Mosti

J Med Chem· March 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and 3D QSAR of new pyrazolo[3,4-b]pyridines: potent and selective inhibitors of A1 adenosine receptors.
Fabrizio Manetti, Silvia Schenone, Francesco Bondavalli, Chiara Brullo, Olga Bruno, Luisa Mosti

J Med Chem· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Insights into structure-activity relationships from lipophilicity profiles of pyridin-2(1H)-one analogs of the cardiotonic agent milrinone.
Modesto de Candia, Paola Fossa, Saverio Cellamare, Luisa Mosti, Angelo Carotti

Eur J Pharm Sci· September 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Structure-based design, parallel synthesis, structure-activity relationship, and molecular modeling studies of thiocarbamates, new potent non-nucleoside HIV-1 reverse transcriptase inhibitor isosteres of phenethylthiazolylthiourea derivatives.
Angelo Ranise, Andrea Spallarossa, Sara Cesarini, Francesco Bondavalli, Silvia Schenone, Luisa Mosti

J Med Chem· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New pyrazolo[3,4-b]pyridones as selective A(1) adenosine receptor antagonists: synthesis, biological evaluation and molecular modelling studies.
Paola Fossa, Marco Pestarino, Giulia Menozzi, Luisa Mosti, Silvia Schenone

Org Biomol Chem· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, biological evaluation and molecular modelling studies on benzothiadiazine derivatives as PDE4 selective inhibitors.
Annalisa Tait, Amedeo Luppi, Armin Hatzelmann, Paola Fossa, Luisa Mosti

Bioorg Med Chem· February 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Antiproliferative activity of new 1-aryl-4-amino-1H-pyrazolo[3,4-d]pyrimidine derivatives toward the human epidermoid carcinoma A431 cell line.
Silvia Schenone, Olga Bruno, Francesco Bondavalli, Angelo Ranise, Luisa Mosti

Eur J Med Chem· November 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis, antimicrobial activity and molecular modeling studies of halogenated 4-[1H-imidazol-1-yl(phenyl)methyl]-1,5-diphenyl-1H-pyrazoles.
Giulia Menozzi, Luisa Merello, Paola Fossa, Silvia Schenone, Angelo Ranise, Luisa Mosti

Bioorg Med Chem· October 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pyrazolo[3,4-d]pyrimidines endowed with antiproliferative activity on ductal infiltrating carcinoma cells.
Fabio Carraro, Annalisa Pucci, Antonella Naldini, Silvia Schenone, Olga Bruno, Luisa Mosti

J Med Chem· March 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of 1-(2-chloro-2-phenylethyl)-6-methylthio-1H-pyrazolo[3,4-d]pyrimidines 4-amino substituted and their biological evaluation.
Silvia Schenone, Olga Bruno, Francesco Bondavalli, Angelo Ranise, Luisa Mosti

Eur J Med Chem· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis and pharmacological characterization of functionalized 2-pyridones structurally related to the cardiotonic agent milrinone.
Paola Fossa, Giulia Menozzi, Paola Dorigo, Maura Floreani, Luisa Mosti

Bioorg Med Chem· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Synthesis of N-substituted-N-acylthioureas of 4-substituted piperazines endowed with local anaesthetic, antihyperlipidemic, antiproliferative activities and antiarrythmic, analgesic, antiaggregating actions.
Angelo Ranise, Andrea Spallarossa, Olga Bruno, Silvia Schenone, Paola Fossa, Luisa Mosti

Farmaco· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
4
4-substituted 1,5-diarylpyrazole, analogues of celecoxib: synthesis and preliminary evaluation of biological properties.
Giulia Menozzi, Luisa Merello, Paola Fossa, Luisa Mosti, Antonietta Piana

Farmaco· September 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis